Navigation Links
NCPA Commends Senate Aging Committee for Launching CVS Caremark Investigation to Examine Alleged Harm to Seniors, Medicare

ALEXANDRIA, Va., Sept. 29 /PRNewswire-USNewswire/ -- The National Community Pharmacists Association (NCPA) expressed strong support for an investigation into CVS Caremark launched by the U.S. Senate Special Committee on Aging reported earlier today on the blog Pharmalot.



In response, NCPA President Joseph H. Harmison, PD and Arlington, Texas pharmacy owner, issued the following statement:

"Complaints continue to increase from patients and community pharmacists alleging CVS Caremark of engaging in anti-consumer, anti-competitive behavior. We commend Chairman Herb Kohl (D-Wisc.) for doing the right thing on behalf of patients and pharmacists in Wisconsin and across the nation.  Seniors are both the most in need of pharmacy services and the patients arguably most vulnerable to the misleading and deceptive tactics of which CVS Caremark is accused.

"CVS Caremark's strong-armed efforts to gain market share appear to be compromising patient care while inflating costs for seniors, the Medicare program and taxpayers. For example, retirees Max and Jan Hauser discovered that, under their Medicare drug plan administered by CVS Caremark, the cholesterol drug Simvastatin that cost them nothing at a local independent pharmacy cost them $165.99 at CVS for a three-month supply. As reported by WCNC-TV they were also charged more by CVS for ulcer drugs and blood pressure medicine. The combined higher costs charged by CVS pushed the fixed-income couple into their plan's coverage gap (or 'donut hole') sooner, significantly increasing their out-of-pocket drug costs.

"In addition, seniors who prefer the face to face service and counseling of their independent community pharmacist are forced by CVS Caremark to switch to its mail order or to travel greater distances to the nearest CVS location. In the newly released J.D. Power and Associates 2010 National Pharmacy Study, patients rated CVS Caremark retail and mail order pharmacies significantly lower than its rivals in customer satisfaction.

"The Senate committee joins a long and growing list of investigations into anti-consumer, anti-competitive allegations against CVS Caremark. The Federal Trade Commission is in the midst of a non-public investigation involving both its Bureaus of Competition and Consumer Protection and with the support of dozens of members of Congress. In addition, approximately 24 states are pursuing their own investigations. Community pharmacists and their patients are looking for comprehensive relief from the FTC and other regulators to stop any anti-competitive and deceptive practices by CVS Caremark."

The National Community Pharmacists Association (NCPA®) represents America's community pharmacists, including the owners of more than 22,700 independent community pharmacies, pharmacy franchises, and chains. Together they represent an $88 billion health-care marketplace, employ over 65,000 pharmacists, and dispense over 40% of all retail prescriptions. To learn more go to or read NCPA's blog, The Dose, at

SOURCE National Community Pharmacists Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
2. CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes
3. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
4. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
5. Lung Cancer Alliance Commends NCCN on Screening Guidelines
6. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
7. Task Force Recommends Screening for Hearing Loss in All Newborns
8. CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
9. Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout
10. CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors
11. Independent Data Monitoring Committee Recommends Resuming Enrollment of Non-Squamous NSCLC Patients in the Motesanib MONET1 Trial
Post Your Comments:
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , , , WHEN: , , ... , , , LOCATION: , , , Online, with free registration ... PANELISTS:  , , , Frost & Sullivan,s Global Vice President of ... Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... witnessing an exceptional era. Several new demand spaces, such as innovative ...
(Date:6/23/2016)... 23, 2016 The vast majority of dialysis ... facility.  Treatments are usually 3 times a week, with ... including travel time, equipment preparation and wait time.  This ... grueling for patients who are elderly and frail.  Many ... and rehabilitation centers for some duration of time. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):